Page last updated: 2024-09-03

lestaurtinib and Hodgkin Disease

lestaurtinib has been researched along with Hodgkin Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Artells, R; Bellosillo, B; Diaz, T; Ferrer, G; Garcia-Garcia, M; Gaya, A; Gel, B; Martínez, A; Monzo, M; Navarro, A; Serrano, S	1
Bräuninger, A; Gattenlöhner, S; Holz, MS; Janning, A; Renné, C; Spieker, T	1

Other Studies

2 other study(ies) available for lestaurtinib and Hodgkin Disease

Article	Year
Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis. PloS one, 2011, Apr-20, Volume: 6, Issue:4 Topics: Adult; Apoptosis; Blotting, Western; Carbazoles; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Furans; Hodgkin Disease; Humans; Janus Kinases; Male; Protein Kinase Inhibitors; STAT Transcription Factors	2011
Induction of endoplasmic reticulum stress by sorafenib and activation of NF-κB by lestaurtinib as a novel resistance mechanism in Hodgkin lymphoma cell lines. Molecular cancer therapeutics, 2013, Volume: 12, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carbazoles; Cell Line, Tumor; Drug Interactions; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Furans; Hodgkin Disease; Humans; NF-kappa B; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Reed-Sternberg Cells; Signal Transduction; Sorafenib	2013

Article

Year

Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis.

PloS one, 2011, Apr-20, Volume: 6, Issue:4

Topics: Adult; Apoptosis; Blotting, Western; Carbazoles; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Furans; Hodgkin Disease; Humans; Janus Kinases; Male; Protein Kinase Inhibitors; STAT Transcription Factors

2011

Induction of endoplasmic reticulum stress by sorafenib and activation of NF-κB by lestaurtinib as a novel resistance mechanism in Hodgkin lymphoma cell lines.

Molecular cancer therapeutics, 2013, Volume: 12, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carbazoles; Cell Line, Tumor; Drug Interactions; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Furans; Hodgkin Disease; Humans; NF-kappa B; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Reed-Sternberg Cells; Signal Transduction; Sorafenib

2013